Brief: FDA Says Getinge & Maquet Cardiovascular Update Use Instructions For Vasoview HemoPro 2 (Vh-4000 And Vh-4001) EVH Systems
Jan 15 (Reuters) - FDA:
* FDA: GETINGE AND MAQUET CARDIOVASCULAR UPDATE USE
INSTRUCTIONS
FOR VASOVIEW HEMOPRO 2 (VH-4000 AND VH-4001) EVH SYSTEMS -
WEBSITE
* FDA: 7 REPORTED SERIOUS INJURIES RELATED TO GETINGE &
MAQUET
CARDIOVASCULAR VASOVIEW HEMOPRO 2 (VH-4000 AND VH-4001) EVH
SYSTEMS
* FDA: USE INSTRUCTIONS UPDATE FOR SOME GETINGE VASOVIEW
HEMOPRO 2
EVH SYSTEMS DUE TO POSSIBILITY OF TWO FAILURE MODES EXPERIENCED
DURING USE
Further company coverage: GETIb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Getinge publ AB
See all newsEurope Research Roundup: Akzo Nobel, Handelsbanken, RS Group
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix (updated)
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix
Sweden's Getinge Q3 organic sales rise 2.1%
Brief: Getinge Q3 Adjusted EBITA SEK 1,278 Million